Roivant Sciences Ltd. Common Shares (ROIV) is a publicly traded Healthcare sector company. As of August 19, 2026, ROIV trades at $37.65 with a market cap of $26.18B and a P/E ratio of -103.24. ROIV moved +0.75% today. Year to date, ROIV is +72.21%; over the trailing twelve months it is +216.43%. Its 52-week range spans $8.73 to $37.46. Analyst consensus is strong buy with an average price target of $42.29. Rallies surfaces ROIV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ROIV, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $37.65 |
| Market Cap | $26.18B |
| P/E Ratio | -103.24 |
| EPS | $-0.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.46 |
| 52-Week Low | $8.73 |
| Volume | 342 |
| Avg Volume | 0 |
| Revenue (TTM) | $7.53M |
| Net Income | $-414.60M |
| Gross Margin | 0.00% |
7 analysts cover ROIV: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.29.